Medical Robots Transforming Healthcare – Pricing & Cost-Benefit Assessment (Price Variation (by Product (Surgical Robots, Rehabilitation Robotics, Stereotactic Radiosurgery), by Application, by Geography), Reimbursement, Selection Criteria, Buying Cycle
Medical robotics is an emerging field in healthcare that has been causing a paradigm shift in healthcare as it improves the quality of patient care. Demographic change, shortage of healthcare professionals, need to improve quality of life for the disabled and elderly, and need to improve surgical procedures coupled with the focus to develop technologically advanced robots are some of the factors expected to stimulate the adoption of medical robots.
Medical robots are igniting interest of all the stakeholders in the healthcare industry physicians, health care professionals, providers, payers, technologists, planners and even the government. For instance, citing the benefits offered by rehabilitation robots, Japan's Health Ministry has approved Cyberdyne's HAL exoskeleton suit as a medical device thus covering it under the public health insurance system. Similarly, in July 2015, ReWalk Robotics became the first company to secure commercial reimbursement in the U.S.
To increase the access to this expensive technology, manufacturers have been offering varied financing options to the healthcare providers. Some of the options include leasing, pay-per-use, bundled payments, rental agreements, and expanded payment terms, among others. In addition, the manufacturers are coming up with a low cost products such as Zeno R25 (rehabilitation robot by RoboKind) and SurgiBot (by TransEntrix). Moreover, some of the companies follow differential pricing across geographies. For instance, Europe being a price sensitive market is offered the da Vinci robot at discounted price.
Stakeholders
- Medical Robots and Related Devices Manufacturing Companies
- Suppliers and Distributors of Medical Robotic Systems
- Hospitals
- Ambulatory Surgery Centers
- Radiology Centers
- Rehabilitation Centers
- Pharmacies
- Academic Centers
- Venture Capitalists
To know about the assumptions considered for the study, download the pdf brochure
Want to explore hidden markets that can drive new revenue in Medical Robots Transforming Healthcare ?
This report provides qualitative assessment of the price variation in medical robots of varied types (surgical/rehabilitation/non-invasive radiosurgery/hospital & pharmacy), selection criteria of adopting medical robots from end-user perspective, buying cycle, price wars, and cost-benefits offered by the robots based on existing research studies.
Pricing Landscape
-
Indicative Price List
- Surgical Robots
- Rehabilitation Robots
- Non-Invasive Radiosurgery Systems (Robot-Based)
- Hospital & Pharmacy Robots
Expected Price War (Intuitive vs. Competition)
Reimbursement Landscape, By Region
- Surgical Robots
- Rehabilitation Robots
- Non-Invasive Radiosurgery Systems (Robot-Based)
Major Price Determinants
Financing Options Assessment
- Surgical Robots
- Rehabilitation Robots
- Non-Invasive Radiosurgery Systems (Robot-Based)
- Hospital & Pharmacy Robots
Key Influencers & Decision-Makers
- Surgical Robots
- Rehabilitation Robots
- Non-Invasive Radiosurgery Systems (Robot-Based)
- Hospital & Pharmacy Robots
Key Selection Criteria for End-User
- Surgical Robots
- Rehabilitation Robots
- Non-Invasive Radiosurgery Systems (Robot-Based)
- Hospital & Pharmacy Robots
Buying Cycle Assessment
Marketing & Promotions Strategies Adopted by Vendors
- Surgical Robots
- Rehabilitation Robots
- Non-Invasive Radiosurgery Systems (Robot-Based)
- Hospital & Pharmacy Robots
Cost-Benefit Assessment (Based on Research Studies & Expert Opinions)
-
Surgical Robots
- Cost-benefit Studies
- Industry Speaks
-
Rehabilitation Robots
- Economic Impact of Rehabilitation Robots Vis-À-Vis Disease Burden
- Cost-benefit Studies
- Industry Speaks
-
Non-Invasive Radiosurgery Systems (Robot-Based)
- Cost-benefit Studies
- Industry Speaks
-
Hospital & Pharmacy Robots
- Cost-benefit Studies
- Industry Speaks
Medical robots are increasingly being adopted by hospitals and patients across the globe, particularly in the U.S. Demographic change, shortage of healthcare professionals, need to improve quality of life for the disabled and elderly, and need to improve surgical procedures coupled with the focus to develop technologically advanced robots are some of the factors expected to stimulate growth the adoption of medical robots.
This report provides qualitative assessment of medical robots (surgical/rehabilitation/non-invasive radiosurgery/hospital & pharmacy) in terms of prices of different types of robots, price variation by application & geography, reimbursements of medical robots, buying cycle, financing options available to the end-users to access the technology, price wars among market players, marketing & promotional strategies focused by the vendors, and cost-benefit assessment based on research studies and expert opinions.
The application and technology form the two important components that guide the final pricing of a medical robot. For instance, the surgical robots for laparoscopic applications are most expensive as compared to surgical robots for other applications. In addition, technological variation further creates price variation, an example for which is the named Zeno R25 (rehabilitation robot by RoboKind) which is expected to be launched in retail space at a price tag of USD 2,700. To cut the cost in R25, the manufacturers reduced the number of motors below the waist from 12 to three while still allowing the robot to walk and turn.
Medical Robotics being a highly sophisticated technology showcases slow adoption due to economic hurdles. However, medical robots have become an extremely popular topic over the last few years. Thus, the cost-benefit assessment has taken center stage in the industry and is dominating almost every conversation and headlining several conferences in the field of robotics. The report has provided cost-benefit assessment covering cost benefit studies and industry opinion. The section provides a guideline to the stakeholders in understanding the investment structure and the cost-savings achieved through the use of each type of robot. To increase the access to this expensive technology, manufacturers have been offering varied financing options to the healthcare providers. Some of the options include leasing, pay-per-use, bundled payments, rental agreements, and expanded payment terms, among others.
Frequently Asked Questions (FAQ):
What is the size of Medical Robots Transforming Healthcare ?
Medical robotics is an emerging field in healthcare that has been causing a paradigm shift in healthcare as it improves the quality of patient care.
What are the major growth factors of Medical Robots Transforming Healthcare ?
Medical robots are increasingly being adopted by hospitals and patients across the globe, particularly in the U.S. Demographic change, shortage of healthcare professionals, need to improve quality of life for the disabled and elderly, and need to improve surgical procedures coupled with the focus to develop technologically advanced robots are some of the factors expected to stimulate growth the adoption of medical robots. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Table of Contents
1 Introduction
2 Medical Robots: Pricing Landscape
2.1 Introduction
2.2 Indicative Price List
2.2.1 Surgical Robots
2.2.2 Rehabilitation Robots
2.2.3 Non-Invasive Radiosurgery Systems (Robot-Based)
2.2.4 Hospital & Pharmacy Robots
2.3 Price Variation Assessment
2.3.1 By Application
2.3.1.1 Surgical Robots
2.3.1.2 Rehabilitation Robots
2.3.1.3 Non-Invasive Radiosurgery Systems (Robot-Based)
2.3.2 By Geography
2.3.2.1 Surgical Robots
2.3.2.2 Hospital & Pharmacy Robots
2.3.2.3 Non-Invasive Radiosurgery Systems (Robot-Based)
3 Expected Price War: Surgical Robots Market (Intuitive vs Competition)
4 Medical Robots: Reimbursement Landscape, By Region
4.1 Surgical Robots
4.2 Rehabilitation Robots
4.3 Non-Invasive Radiosurgery Systems (Robot-Based)
5 Medical Robots: Major Price Determinants
6 Medical Robots: Financing Options Assessment
6.1 Surgical Robots
6.2 Rehabilitation Robots
6.3 Non-Invasive Radiosurgery Systems (Robot-Based)
6.4 Hospital & Pharmacy Robots
7 Medical Robots: Key Influncers & Decision-Makers
7.1 Surgical Robots
7.2 Rehabilitation Robots
7.3 Non-Invasive Radiosurgery Systems (Robot-Based)
7.4 Hospital & Pharmacy Robots
8 Medical Robots: Key Selection Criteria for End-User
8.1 Surgical Robots
8.2 Rehabilitation Robots
8.3 Non-Invasive Radiosurgery Systems (Robot-Based)
8.4 Hospital & Pharmacy Robots
9 Medical Robots: Buying Cycle Assessment
10 Medical Robots: Marketing & Promotions Strategies Adopted By Vendors
10.1 Surgical Robots
10.2 Rehabilitation Robots
10.3 Non-Invasive Radiosurgery Systems (Robot-Based)
10.4 Hospital & Pharmacy Robots
11 Cost-Benefit Assessment (Based on Research Studies & Expert Opinions)
11.1 Surgical Robots
11.1.1 Cost-Benefit Studies
11.1.1.1 A Da Vinci Robot System Can Make Sensefor A Mature Laparoscopic Prostatectomy Program
11.1.1.2 Robot-Assisted Surgery Compared With Open Surgery and Laparascopic Surgery: Clinical Effectiveness and Economic Analyses
11.1.2 Industry Speaks
11.2 Rehabilitation Robots
11.2.1 Economic Impact of Rehabilitation Robots Vis-À-Vis Disease Burden
11.2.2 Cost-Benefit Studies
11.2.2.1 an Economic Analysis of Robot-Assisted Therapy Fro Long-Term Upper-Limb Imparement After Stroke
11.2.3 Industry Speaks
11.3 Non-Invasive Radiosurgery Systems (Robot-Based)
11.3.1 Cost-Benefit Studies
11.3.1.1 A Comparative Study of Gamma Knife Radiosurgery Versus Open Surgery for Intracranial Pathology
11.3.1.2 Outcomes and Cost-Effectiveness of Gamma Knife Radiosurgery and Whole-Brain Radiotherapy for Multiple Metastatic Brain Tumors
11.3.1.3 Cost-Effectiveness Analysis of A Randomized Study Comparing Radiosurgery With Radiosurgery and Whole Brain Radition Therapy in Patients With 1 to 3 Brain Metastases
11.3.1.4 Cyberknife for Prostrate Cancer: is It Cost-Effective
11.3.1.5 Tomotherapy, Gamma Knife, and Cyberknife Therapies for Patients With Tumors of the Lung, Central Nervous System, Or Intra-Abdomen: A Systematic Review of Clinical Effectiveness and Cost-Effectiveness
11.3.2 Industry Speaks
11.4 Hospital & Pharmacy Robots
11.4.1 Cost-Benefit Studies
11.4.1.1 Impact of Robotic Dispensing Machines in German Pharmacies on Business Performance Indicators
11.4.1.2 Recent Trends in the Usage of Robotics in Pharmacy
11.4.1.3 Cover Story - Rise of Machines
11.4.1.4 Automated Medication Dispensing Systems : A Review of the Clinical Benefits, Harms, and Cost-Effectiveness
11.4.2 Industry Speaks
12 Appendix
12.1 Indicative List of Research Studies Highlighted on Company Websites
12.1.1 Intutive Surgicals
12.1.2 Mazor Robotics
12.1.3 Varian Medical Systems
12.1.4 Elekta AB
12.1.5 Hocoma AG
12.1.6 Rewalk
12.2 Sources: Indicative List of Research Studies Highlighted on Company Websites
List of Tables (33 Tables)
Table 1 Surgical Robots: Indicative Price List
Table 2 Rehabilitation Robots: Indicative Price List
Table 3 Non-Invasive Radiosurgery Systems (Robotic-Based): Indicative Price List
Table 4 Hospital & Pharmacy Robots: Indicative Price List
Table 5 Surgical Robots: Price Variation, By Application
Table 6 Various Specifications for Da Vinci Xi, Si, and Si-E
Table 7 Price Variations for Non-Invasive Radiosurgery Systems (Robot-Based), By Brand
Table 8 Price Variations for Surgical Robots, By Geography
Table 9 Price Variations for Rehabilitation Robots, By Geography
Table 10 Price Variations for Hospital & Pharmacy Robots, By Geography
Table 11 Cyberknife Installation, By Region
Table 12 Gamma Knife Installation, By Region
Table 13 Approximate Cyberknife & Gamma Knife Procedure Cost, By Region
Table 14 Surgical Robots: Price War Competition Analysis
Table 15 Reimbursement Details: Changes in Total Global Payment for Single Session Extracranial and Multisession SRS (Stereotactic Radiosurgery)/SBRT (Stereotactic Body Radiation Therapy)
Table 16 Average and Incremental Per-Patient Costs of Robot Assisted Radical Prostatectomy (Rarp), Open Radical Prostatectomy (ORP), and Laparoscopic Radical Prostatectomy (Lrp)
Table 17 Undiscounted Per Center Costs of Da Vinci Robot, Maintenance, Consumables, and Training, By Year
Table 18 Share of Road Traffic Inuries Mortality in Leading Cause of Deaths World-Wide 2004
Table 19 Share of Road Traffic Inuries Mortality in Leading Cause of Deaths World-Wide 2030
Table 20 Hourly Rehabilitation Robot Cost
Table 21 Hourly Physiotherapist Cost
Table 22 Hourly Robot-Aided Therapy Cost (Including Physiotherapist Cost)
Table 23 Comparison of Robot-Assisted Reahbilitation Therapy and Conventional Therapy
Table 24 A Comparison of Average 12 Month Costs of Treating Patients With Open and Gamma Knife Radiosurgery (GKRS)
Table 25 A Comparison of Gamma Knife Radiosurgery (GKRS) and Whole Brain Radiotherapy (WBRT)
Table 26 A Comparison of ‘Stereotactic Radiosurgery (SRS)+ Observation’ and ‘SRS + Whole Brain Radiation Therapy (WBRT)’
Table 27 A Comparison of Total Lifetime Costs of Surgery, Cyberknife (CK), Intensity Modulated Radiation Therapy (IMRT), and Proton Therapy (PT)
Table 28 A Comparison of Base Case Average Capital Equipment Costs Per Patient for Gamma Knife (GK), Cyberknife (CK), and Other Linac Systems
Table 29 Sample Calculation of the Total Costs of A Robotic Dispensing Machine
Table 30 Comparison of Rowa Vmax, Go.Compact, Robopharma, and Consis
Table 31 Relative Risk Reduction (RRR) Or Relative Risk Increase (RRI) Comparison of Automated Dispensing Devices (ADD) in Different Set-Ups
Table 32 Five-Year Drug Distribution Costs of Automated Dispensing Devices (ADD)
Table 33 Accuracy Rates Before and After Implementation of A Carousel Dispensing Technology (CDT)
List of Figures (21 Figures)
Figure 1 Medical Robots: A Historical Timeline
Figure 2 Medical Robots, By Product Segmentation
Figure 3 Factors Responsible for Price Variation in Medical Robots
Figure 4 Surgical Robots: Price Variation, By Application
Figure 5 Price Variations for Laparoscopy Robots, By Brand
Figure 6 Price Variations for Da Vinci Robots, By Type
Figure 7 Price Variations for Steerable Robotic Catheter Systems, By Brand
Figure 8 Price Variations for Neurology Robots, By Brand
Figure 9 Price Variations for Orthopedic Robots, By Brand
Figure 10 Price Variations for Rehabilitation Robots, By Type & Brand
Figure 11 Medical Robots: Major Price Determinants
Figure 12 Medical Robots: Financing Options Assessment, By Type
Figure 13 Medical Robots: Key Stakeholders in Purchase Decision, By Type
Figure 14 Medical Robots: Key Influncers & Decision-Makers
Figure 15 Medical Robots: Key Selection Criteria for End-User, By Type
Figure 16 Medical Robots: Buying Cycle Assessment, By Type
Figure 17 Medical Robots: Marketing & Promotions Strategies, By Type
Figure 18 Surgical Robots: Industry Speaks
Figure 19 Rehabilitation Robots: Industry Speaks
Figure 20 Non-Invasive Radiosurgical Systems (Robot-Based): Industry Speaks
Figure 21 Hospital & Pharmacy Robots: Industry Speaks
Growth opportunities and latent adjacency in Medical Robots Transforming Healthcare